Search research articles
Contact Us
Filters
Showing results (411-420 of 436) with videos related to
Page
of 44
Sort By:
Future Oncology (London, England)
|
June 4, 2020
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412
Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
October 18, 2015
Association of Resting Heart Rate with Infrarenal Aortic Diameter: A Cross Sectional Study in Chinese Hypertensive Adults
R Wei, L S Liu, L W Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2025
Sacituzumab Tirumotecan in Participants With Advanced or Metastatic Urothelial Carcinoma and Disease Progression after Chemotherapy and Immune Checkpoint Inhibitors
Y Zhu, S Jiang, Y Shi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 19, 2020
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA
J Wang, K Cai, X He, et al.
Elife
|
July 31, 2018
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Ji Li, Peter S Choi, Christine L Chaffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Maria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Molecular Cell
|
May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
Shaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Cell Reports
|
December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancer
Bojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Nature
|
November 5, 2020
No pulsed radio emission during a bursting phase of a Galactic magnetar
L Lin, C F Zhang, P Wang, et al.
Physical Review Letters
|
August 27, 2011
Observation of the h(c)(1P) Using e+ e- collisions above the DD threshold
T K Pedlar, D Cronin-Hennessy, J Hietala, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 436) with videos related to
Sort By:
Page
of 44
Future Oncology (London, England)
|
June 4, 2020
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412
Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
October 18, 2015
Association of Resting Heart Rate with Infrarenal Aortic Diameter: A Cross Sectional Study in Chinese Hypertensive Adults
R Wei, L S Liu, L W Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2025
Sacituzumab Tirumotecan in Participants With Advanced or Metastatic Urothelial Carcinoma and Disease Progression after Chemotherapy and Immune Checkpoint Inhibitors
Y Zhu, S Jiang, Y Shi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 19, 2020
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA
J Wang, K Cai, X He, et al.
Elife
|
July 31, 2018
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Ji Li, Peter S Choi, Christine L Chaffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Maria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Molecular Cell
|
May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
Shaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Cell Reports
|
December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancer
Bojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Nature
|
November 5, 2020
No pulsed radio emission during a bursting phase of a Galactic magnetar
L Lin, C F Zhang, P Wang, et al.
Physical Review Letters
|
August 27, 2011
Observation of the h(c)(1P) Using e+ e- collisions above the DD threshold
T K Pedlar, D Cronin-Hennessy, J Hietala, et al.
Page
of 44